Edition:
United Kingdom

Aquinox Pharmaceuticals Inc (AQXP.OQ)

AQXP.OQ on NASDAQ Stock Exchange Global Market

14.78USD
7:32pm GMT
Change (% chg)

$-0.24 (-1.60%)
Prev Close
$15.02
Open
$15.05
Day's High
$15.12
Day's Low
$14.67
Volume
18,229
Avg. Vol
32,037
52-wk High
$18.46
52-wk Low
$10.03

Chart for

About

Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. The Company's primary focus is anti-inflammatory product candidates targeting the Src Homology 2 (SH2)-containing inositol-5-phosphatase 1 (SHIP1) enzyme,... (more)

Overall

Beta: --
Market Cap(Mil.): $332.96
Shares Outstanding(Mil.): 23.46
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-Aquinox Provides Enrollment Update For Leadership 301 Clinical Trial Of Rosiptor

* AQUINOX PROVIDES ENROLLMENT UPDATE FOR LEADERSHIP 301 CLINICAL TRIAL OF ROSIPTOR

09 Feb 2018

BRIEF-‍Aquinox Statement On Fda Advisory Committee Meeting To Discuss Interstitial Cystitis/Bladder Pain Syndrome​

* ‍AQUINOX STATEMENT ON FDA ADVISORY COMMITTEE MEETING TO DISCUSS INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME​

08 Dec 2017

BRIEF-Aquinox Pharmaceuticals qtrly ‍net loss per share $0.50​

* Aquinox Pharmaceuticals announces third quarter 2017 financial results

08 Nov 2017

Earnings vs. Estimates